Compare GLSI & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLSI | CZFS |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.1M | 288.7M |
| IPO Year | 2020 | 1995 |
| Metric | GLSI | CZFS |
|---|---|---|
| Price | $21.90 | $74.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | ★ 130.9K | 8.7K |
| Earning Date | 05-19-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.10% |
| EPS Growth | N/A | ★ 30.26 |
| EPS | N/A | ★ 2.16 |
| Revenue | N/A | ★ $9,881,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.64 |
| P/E Ratio | ★ N/A | $33.43 |
| Revenue Growth | N/A | ★ 2.82 |
| 52 Week Low | $7.78 | $49.99 |
| 52 Week High | $34.10 | $74.70 |
| Indicator | GLSI | CZFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 60.18 |
| Support Level | $21.16 | $53.50 |
| Resistance Level | $29.89 | N/A |
| Average True Range (ATR) | 2.17 | 2.37 |
| MACD | 0.08 | 0.44 |
| Stochastic Oscillator | 61.02 | 74.67 |
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75% of breast cancers.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.